Frederick, MD. Sept 23, 2004 - SABiosciences Corp. announced today the availability of its new GEArray Expression Analysis Suite application software. The new analysis suite is an integrated, web-based application that helps researchers analyze raw microarray images and report gene expression results. The analysis suite provides visual presentations of statistical data analyses (scatter plots, clustergrams, and K means diagrams), as well as reports of normalized intensities, present & absent calls, and color-coded fold-changes.

"SABiosciences produces pathway-focused microarrays with highly relevant gene content for the study of immunology, cancer, signal transduction, apoptosis and more. The focused design of our GEArrays® already reduces the sometimes daunting task of data analysis following microarray detection," said Dr. Sean Yu, Vice President of Operations for SABiosciences Corp. "Additionally, the new analysis suite includes sophisticated features and statistical analysis algorithms to help our customers produce useful information from their gene expression experiments as simply as possible."

The GEArray Expression Analysis Suite application software fits into SABiosciences' product philosophy of making affordable DNA microarray technology available to virtually every laboratory. The analysis suite is available by subscription, making it very affordable. The web-based design provides easy access via the familiar web browser interface from either a Windows PC or Apple Macintosh computer. Gene tables for all of SABiosciences' pathway-focused DNA microarrays (now over 60 designs) are included in the application and are kept current for the user. A tutorial to the new analysis suite is available via web-based seminars.

SABiosciences Corp. develops and markets a wide range of innovative, pathway-focused life science research products. The company's three technology platforms support its complementary toolset for systematic gene expression profiling (DNA microarrays), gene expression verification (conventional and real-time PCR) and gene suppression (siRNA) on a pathway-by-pathway basis. For more information, please visit the company's web site, http://www.sabiosciences.com.